Perfil clínico e epidemiológico de pacientes com COVID-19 atendidos no Hospital Universitário Getúlio Vargas durante a pandemia
DOI:
https://doi.org/10.60104/revhugv10955Keywords:
COVID-19, Epidemic, Epidemiology, Health assistanceAbstract
In December 2019, an epidemic of infections caused by a new coronavirus (SARS-CoV-2) began in China, with a clinical spectrum ranging from asymptomatic infection to severe pneumonia. The objective of this study was to analyze the clinical and epidemiological profile of patients infected with COVID-19 hospitalized in clinical beds and intensive care units at Hospital Universitário Getúlio Vargas. A retrospective descriptive study was carried out from April 2020 to March 2021. The research was submitted to the Research Ethics Committee (CEP/UFAM), approved with CAAE: 50063621.8.0000.5020. A total of 68 participants were included in the study, predominantly in the age group 71-75 years, 51.5% male (n=35), 92.6% brown (n=63), 42.6% married (n =29), 41.1% had completed higher education (n=28) and 61.76% were born in Manaus (n=42). As for associated comorbidities, 58.8% had systemic arterial hypertension (n=40) and 41.1% had diabetes mellitus (n=28). The main symptoms observed were dyspnea (73.5%), fever (72%), dry cough (50%), myalgia (36.7%), diarrhea (22%) and chest pain (19.1%). As for the diagnosis, 48.5% underwent rapid test for COVID (n=33) and 41.1% RT-PCR collected by nasal swab (n=28) with a positive result. Regarding prognosis, 75% of patients (n=51) were discharged for home treatment, 3% (n=2) with cardiovascular complications and 22% (n=15) died. The most susceptible population groups were the elderly and people with preexisting medical conditions, such as cardiovascular diseases, hypertension and diabetes, associated with a significant increase in the risk of hospitalization and a high mortality rate in this population.
Downloads
References
OMS (Organização Mundial da Saúde). Folha informativa COVID-19 – Escritório da OPAS e da OMS no Brasil. Principais informações. Organização Pan-Americana de Saúde. 2020. [online]. Disponível em: https://www.paho.org/pt/brasil.
Silva Fortuna DB, & Fortuna JL. (2020). Perfil epidemiológico dos casos de COVID-19 no município de Teixeira de Freitas-BA. Brazilian Journal of Development, 6(10), 76374–76392. 2020. https://doi.org/10.34117/bjdv6n10-166.
Girão MMF. et al. Perfil Epidemiológico dos Pacientes de SARS-COV-2 no Brasil / Epidemiological Profile of SARS-COV-2 Patients in Brazil. ID on line. Revista de psicologia, [S.l.], v. 14, n. 51, p. 646-658, jul. 2020. ISSN 1981-1179. https://doi.org/10.14295/idonline.v14i51.2605.
Gomes GG et al. (2020). Perfil epidemiológico da Nova Doença Infecciosa do Coronavírus - COVID-19 (Sars-Cov-2) no mundo: Estudo descritivo, janeiro-junho de 2020. Braz. J. Hea. Rev., Curitiba, v. 3, n. 4, p. 7993-8007. jul./aug. 2020. https://doi.org/10.34119/bjhrv3n4-064.
Silva TM. et al. Epidemiological profile of Covid-19 morbidity and mortality in the State of Piauí: an update of the current scenario. Research, Society and Development, [S. l.], v. 9, n. 8, p. e803986091. 2020. https://doi.org/10.33448/rsd-v9i8.6091.
Aquino EML. et al. Medidas de distanciamento social no controle da pandemia de COVID-19: potenciais impactos e desafios no Brasil. Ciência & Saúde Coletiva, v. 25, p. 2423-2446, 2020. https://doi.org/10.1590/1413-81232020256.1.10502020.
Chapman AR, Bularga A, Mills NL. High-Sensitivity Cardiac Troponin can be an ally in the fight against COVID-19. Circulation. 2020 Jun 2; v. 141, n. 22: p. 1733- 1735. https://doi.org/10.1161/CIRCULATIONAHA.120.047008.
Liang W, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. Published online May 12, 2020. https://doi.org/10.1001/jamainternmed.2020.2033.
MINISTÉRIO DA SAÚDE. Definição e Casos Suspeitos [Internet]. Brasil: Ministério da Saúde; 2022. Disponível em: https://www.gov.br/saude/pt-br/coronavirus/artigos/definicao-e-casos-suspeitos.
WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. Disponível em: https://covid19.who.int/.
Baqui P et al. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Londres: Lancet Glob Heal, 2020. https://doi.org/10.1016/S2214-109X(20)30285-0.
FUNDAÇÃO DE VIGILÂNCIA EM SAÚDE DO AMAZONAS. Situação Epidemiológica de COVID-19 e da Síndrome Respiratória Aguda Grave no Estado do Amazonas. BOLETIM_DIÁRIO_DE_CASOS_COVID-19, 16.01.2021, Disponível em: http://www.fvs.am.gov.br/media/publicacao/16_01_21_BOLETIM_DIARIO_DE_CA SOS_COVID-19.pdf.
FUNDAÇÃO DE VIGILÂNCIA EM SAÚDE DO AMAZONAS. Situação Epidemiológica de COVID-19 e da Síndrome Respiratória Aguda Grave no Estado do Amazonas. BOLETIM_DIÁRIO_DE_CASOS_COVID-19, 17.08.22, Disponível em: https://www.fvs.am.gov.br/media/publicacao/17_08_22_BOLETIM_DIÁRIO_DE_C ASOS_COVID-19_2.pdf.
Ceylan Z. Estimation of COVID-19 prevalence in Italy, Spain, and France. Science of the Total Environment, p. 138817, 2020. https://doi.org/10.1016/j.scitotenv.2020.138817.
Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID- 19 in Wuhan, China: a retrospective cohort study: a retrospective cohort study. The Lancet, [s.l.], v. 395, n. 10229, p. 1054-1062, mar. 2020. https://doi.org/10.1016/S0140-6736(20)30566-3.
Zhu J, et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis: a meta-analysis. Family Medicine and Community Health, [s.l.], v. 8, n. 2, abr. 2020. BMJ. https://doi.org/10.1136/fmch-2020-000406.
Almeida JS, et al. Caracterização epidemiológica dos casos de COVID-19 no Maranhão: Uma breve análise. Rev Prev Infec e Saúde [Internet]: 6; 2020. Disponível em: https://preprints.scielo.org/index.php/scielo/preprint/view/314/377
BRASIL. Ministério da Saúde. Conselho Nacional de Saúde. Resolução n. 466, de 12 de dezembro de 2012. Aprova diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Brasília, Diário Oficial da União, 12 dez. 2012. In: Revisão Ética na Pesquisa em Ciências Humanas e Sociais. Educação & Sociedade, Campinas, v. 36, n. 133, p. 857-863, 2015 Disponível em: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101- 73302015000400857
Paiva CI, et al. Perfil epidemiológico da Covid-19 no Estado do Paraná. Revista de Saúde Pública do Paraná. [Internet]. 21dez. 2020; 3(Supl.). https://doi.org/10.32811/25954482- 2020v3sup1p39.
Klokner SGM, et al. Perfil epidemiológico e preditores de fatores de risco para a COVID-19 na região sul do Brasil. Research, Society and Development, 2021. https://doi.org/10.33448/rsd-v10i3.13197.
Nascimento IMG, et al. Perfil clínico-epidemiológico dos casos de hospitalização por COVID-19 na nona região de saúde da Paraíba, Brasil. Research, Society and Development, v. 11, n. 1, p. e29011124761, 2022. https://doi.org/10.33448/rsd-v11i1.24761.
Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM. et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. medRxiv; 2020. doi:10.1101/2020.04.15.20067157. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32442528/.
Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS- CoV-2. JAMA. 2020 Jun 9;323(22):2249-2251. https://doi.org/10.1001/jama.2020.8259. PMID:
Khatami F, Saatchi M, Zadeh SST, Aghamir ZS, Shabestari AN, Reis LO, Aghamir SMK. A meta-analysis of accuracy and sensitivity of chest CT and RT- PCR in COVID-19 diagnosis. Sci Rep. 2020 Dec 28;10(1):22402. https://doi.org/10.1038/s41598- 020-80061-2.
Pontes L. et al. Perfil clínico e fatores associados ao óbito de pacientes COVID-19 nos primeiros meses da pandemia. Escola Anna Nery [online]. v. 26, e20210203. 2022. https://doi.org/10.1590/2177-9465-EAN-2021-0203.
Bartoletti M, Azap O, Barac A, et al. ESCMID COVID-19 living guidelines: drug treatment and clinical management. Clin Microbiol Infect. 2022; 28(2): 222-238. https://doi.org/10.1016/j.cmi.2021.11.007.
CENTERS FOR DISEASE CONTROL (US). COVID-19 Associated Hospitalization Related to Underlying Medical Conditions [Internet]. [local desconhecido: Centers for Disease Control and Prevention; 2020. Disponível em: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-underlying-medical-conditions.html.